Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Centerville › NPI 1811940182
Physician

Pain Evaluation & Management Center of Ohio, INC.

Pain Evaluation & Management Center of Ohio, INC. was paid $914K by Medicaid between Jan 2018 and Nov 2024, across 42 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.

33Billing provider infoPAIN EVALUATION & MANAGEMENT CENTER OF OHIO, INC.
CENTERVILLE, OH 45458
33aNPI1811940182assigned 05/18/2006
28Total paid$914K
24GClaims34,276
24DCodes billed42
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Family Medicine Physician providers in Ohio

Rank by total paid#72 of 739
Median peer was paid$30K
This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20183,560$39K
20192,697$39K
20205,308$81K
20215,899$154K
20227,182$245K
20235,355$205K
2024incomplete4,275$150K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 37% 10,097 9,257 $335K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 33% 14,813 13,697 $300K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 14% 991 930 $124K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 10% 2,441 2,292 $93K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.0% 250 244 $18K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 601 235 $8K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 33 31 $5K
E0730 Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation <1% 14 12 $2K
80346 <1% 107 105 $2K
01992 <1% 54 40 $2K
80363 <1% 107 105 $2K
80361 <1% 107 105 $2K
30 more codes
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 99 $2K
83992 <1% 107 $1K
99203 Doctor's office visit, new patient (routine) <1% 26 $1K
80349 <1% 107 $1K
80353 <1% 107 $1K
80358 <1% 107 $1K
80359 <1% 107 $1K
80354 <1% 107 $1K
80365 <1% 107 $1K
80373 <1% 107 $1K
80372 <1% 107 $1K
80348 <1% 107 $1K
80355 <1% 107 $1K
80356 <1% 107 $1K
80366 <1% 107 $1K
80325 <1% 105 $983.10
62370 <1% 42 $862.52
76942 <1% 26 $606.69
80345 <1% 53 $483.32
80336 <1% 53 $483.32
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 162 $455.68
80323 <1% 53 $453.34
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 29 $277.73
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 62 $238.34
A4649 Surgical supply; miscellaneous <1% 1,369 $185.66
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 140 $130.61
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 277 $129.51
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 298 $20.00
A4215 Needle, sterile, any size, each 0% 413 $0.00
A4550 Surgical trays 0% 63 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDONNINI, RICHARD (CO-OWNER)